You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gliosarcoma

Showing 1 - 25 of 458
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular

Completed
Has Results
  • Gliosarcoma
  • Recurrent Glioblastoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 5, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Glioblastoma Multiforme of Brain, Glioma, Sarcomatous Trial in Buffalo (photochemo using

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • Glioma, Sarcomatous
  • photochemotherapy using 3-(1-Butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-n-butylimide methyl ester(Photobac®)
  • Buffalo, New York
    Roswell Park Cancer
Sep 26, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV Trial in Ann Arbor (drug, radiation, procedure)

Recruiting
  • Recurrent Glioblastoma
  • +5 more
  • Mycophenolate Mofetil
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 7, 2022

Glioblastoma Through Preservation of Biologically Active Brain

Not yet recruiting
  • Glioblastoma
  • +2 more
  • Specimen Collection
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 24, 2023

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

Active, not recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)

Active, not recruiting
Has Results
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,

Terminated
Has Results
  • Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
  • Chemotherapy with Temodar.
  • Radiation therapy
  • Baltimore, Maryland
    Ummc Msgcc
Dec 1, 2022

Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

Active, not recruiting
  • Glioblastoma Multiforme of Brain
  • +2 more
  • C134
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 19, 2022

Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)

Terminated
Has Results
  • Gliosarcoma
  • Central Nervous System Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 24, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Atlanta (Liothyronine, Lomustine, Methimazole)

Recruiting
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 23, 2022

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • bevacizumab
  • +5 more
  • Los Angeles, California
  • +2 more
Feb 10, 2022

Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived

Not yet recruiting
  • Recurrent Gliosarcoma
  • +2 more
  • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
  • Resection
  • Houston, Texas
    M D Anderson Cancer Center
May 24, 2022

Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • +2 more
  • M032 (NSC 733972)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 26, 2022

Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic

Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Glioblastoma, Gliosarcoma Trial in Miami, Atlanta, Baltimore (radiation, procedure, drug)

Active, not recruiting
  • Glioblastoma
  • Gliosarcoma
  • Dose-Escalated Radiation Therapy
  • +2 more
  • Miami, Florida
  • +2 more
Feb 16, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    High Grade Astrocytic Tumor, Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma Trial in Rochester (Biospecimen

    Not yet recruiting
    • High Grade Astrocytic Tumor
    • +2 more
    • Biospecimen Collection
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 18, 2022